DIO Corporation

KOSDAQ 039840.KQ

DIO Corporation EBITDA for the year ending December 31, 2023: USD 23.38 M

DIO Corporation EBITDA is USD 23.38 M for the year ending December 31, 2023, a 1,154.99% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

DIO Corporation EBITDA for the year ending December 31, 2022 was USD -2.22 M, a -105.33% change year over year.
DIO Corporation EBITDA for the year ending December 31, 2021 was USD 41.59 M, a 53.46% change year over year.
DIO Corporation EBITDA for the year ending December 31, 2020 was USD 27.10 M, a -24.00% change year over year.
DIO Corporation EBITDA for the year ending December 31, 2019 was USD 35.66 M, a 185.20% change year over year.

Key data

Date	EBITDA	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)

KOSDAQ: 039840.KQ

DIO Corporation

CEO	Mr. Jin-Baek Kim
IPO Date	Sept. 14, 2000
Location	South Korea
Headquarters	66, Centum seo-ro
Employees	376
Sector	Health Care
Industries Dental Care Medical Instruments Pharmaceuticals

Description

DIO Corporation manufactures and sells dental implants in South Korea. It offers implant systems, which include UFII int. submerged and no-submerged systems, FTN external systems, protem mini systems, UV active and activators, and instrument kits. The company also provides dental digital solutions and dental products; and cardiovascular medical devices. In addition, it exports its products to approximately 70 countries. The company was formerly known as DSI Co., Ltd and changed its name to DIO Corporation in August 2008. DIO Corporation was founded in 1988 and is headquartered in Busan, South Korea.

Key trends

Past 5 years